Close
Back to CWBR Stock Lookup

CohBar (CWBR) – Press Releases

Nov 27, 2023 06:05 PM CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
Aug 14, 2023 04:01 PM CohBar Reports Second Quarter 2023 Financial Results
Jun 5, 2023 08:05 AM Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (
May 30, 2023 08:05 AM Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2023 07:30 AM CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
May 23, 2023 07:30 AM CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
Nov 8, 2022 04:03 PM CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Nov 8, 2022 04:03 PM CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Oct 26, 2022 09:00 AM CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Oct 26, 2022 09:00 AM CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Sep 22, 2022 09:00 AM CohBar Announces Reverse Stock Split
Sep 22, 2022 09:00 AM CohBar Announces Reverse Stock Split
Sep 6, 2022 09:00 AM CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference
Sep 6, 2022 09:00 AM CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference
Aug 15, 2022 04:02 PM CohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Aug 15, 2022 04:02 PM CohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Aug 1, 2022 09:00 AM CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
Aug 1, 2022 09:00 AM CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
Jul 12, 2022 09:00 AM CohBar Appoints Effie Tozzo, Ph.D. to Its Board of Directors
Jul 12, 2022 09:00 AM CohBar Appoints Effie Tozzo, Ph.D. to Its Board of Directors
Jun 7, 2022 09:00 AM CohBar to Participate at Upcoming Conferences in June 2022
Jun 7, 2022 09:00 AM CohBar to Participate at Upcoming Conferences in June 2022
May 19, 2022 04:02 PM CohBar to Present at the H.C. Wainwright Global Investment Conference
May 19, 2022 04:02 PM CohBar to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022 04:01 PM CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress
May 16, 2022 04:01 PM CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress
May 12, 2022 09:00 AM CohBar Announces Extension of Nasdaq Compliance Period and Summarizes 2022 Annual Meeting Proposal
May 12, 2022 09:00 AM CohBar Announces Extension of Nasdaq Compliance Period and Summarizes 2022 Annual Meeting Proposal
May 2, 2022 09:00 AM CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
May 2, 2022 09:00 AM CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
Mar 29, 2022 04:01 PM CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Mar 29, 2022 04:01 PM CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Mar 15, 2022 09:00 AM CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022
Mar 15, 2022 09:00 AM CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022
Jan 3, 2022 09:00 AM CohBar to Present at H.C. Wainwright BIOCONNECT Conference
Jan 3, 2022 09:00 AM CohBar to Present at H.C. Wainwright BIOCONNECT Conference
Dec 17, 2021 09:00 AM CohBar Announces Changes to its Board of Directors and R&D Leadership
Dec 17, 2021 09:00 AM CohBar Announces Changes to its Board of Directors and R&D Leadership
Nov 29, 2021 09:00 AM CohBar’s CEO to Participate in Upcoming BIO Webinar
Nov 29, 2021 09:00 AM CohBar’s CEO to Participate in Upcoming BIO Webinar
Nov 15, 2021 04:02 PM CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 15, 2021 04:02 PM CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 1, 2021 09:00 AM CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021
Nov 1, 2021 09:00 AM CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021
Oct 28, 2021 08:45 AM CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
Oct 28, 2021 08:45 AM CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
Oct 27, 2021 04:01 PM CohBar Announces Proposed Public Offering of Common Stock and Warrants
Oct 27, 2021 04:01 PM CohBar Announces Proposed Public Offering of Common Stock and Warrants
Oct 13, 2021 09:00 AM CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021
Oct 13, 2021 09:00 AM CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021

Back to CWBR Stock Lookup